Bill116th CongressFiled Sep 27, 2019Health
H.R. 4553
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Sep 27, 2019)
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
What just happenedSep 30, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Boyle, Brendan F. [D-PA-2](D-PA)Sponsor
4 cosponsors1 D3 R
4cosponsors1committees4actions4subjects
- Introduced in HouseSep 27, 2019
- Sep 30, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 27, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 27, 2019IntroReferralIntro-H
Introduced in House
- Sep 27, 2019IntroReferral1000
Introduced in House